A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer.

A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer. Int J Radiat Oncol Biol Phys. 2020 07 01; 107(3):487-498.

View in: PubMed

subject areas

Adult
Chemoradiotherapy
DNA-Binding Proteins
Female
Human papillomavirus 16
Human papillomavirus 18
Humans
Middle Aged
Oncogene Proteins, Viral
Papillomavirus E7 Proteins
Repressor Proteins
Safety
Uterine Cervical Neoplasms
Vaccines, DNA

authors with profiles

Yasmin Hasan
Ralph R. Weichselbaum
Daniel W. Golden
Gini Fleming
Anne R. Mccall